International Clinical Neurosience Journal

🩺🌸 Assessing Demoralization in Breast Cancer Patients: Persian Version of the Demoralization Scale (DS-II) 🌸🩺 📚 Just Published in the Journal of Research in Medical Sciences (March 2024) 📚 Background: Demoralization, characterized by existential distress and despair, is common among cancer patients. The Demoralization Scale (DS-II), a self-administered tool with 16 items, assesses two factors: meaning and purpose, and distress and coping ability. Key Findings: Study Cohort: 240 women with breast cancer participated. Reliability: DS-II demonstrated good internal consistency (Cronbach’s alpha: 0.67 for meaning and purpose, 0.72 for distress and coping ability, and 0.81 for the total score). Validity: Confirmatory factor analysis confirmed the two-factor structure. Convergent and divergent validity were also established, showing correlations with related constructs. Conclusion: The Persian version of DS-II exhibits robust psychometric properties. It serves as a reliable tool for assessing demoralization in women with breast cancer, aiding in comprehensive patient care. 🔗 Read more: https://lnkd.in/duj5-359 This study contributes to understanding and addressing the psychological aspects of breast cancer, facilitating tailored interventions and support for affected individuals. #BreastCancer #Demoralization #PsychometricAssessment #MedicalResearch #JRMS 🎗️🧠

2

I am always excited when I see literature pertaining to traditional medicines that I haven't had a lot of exposure to. Yes, my background is in Traditional Chinese Medicine (TCM) but this is another example of cross exposure of medicinal plants from other cultures. Herbal medicine stems back thousands of years and the more we share the knowledge, the more we can learn from each framework and medical paradigm. Congratulations and best of luck to the authors for their new publication on Traditional Persian Medicine. #naturalmedicine #herbalmedicine #traditionalpersionmedicine #phytoceuticals

3

I am thrilled to share that my article titled "Angiotensin-converting enzyme I/D gene polymorphism and risk of type 2 diabetes mellitus in Iranian individuals" has been published! This research sheds light on the impact of genetic variations on the risk of developing type 2 diabetes among individuals in Iran. The study explores the association between angiotensin-converting enzyme gene polymorphism and the susceptibility to type 2 diabetes mellitus, providing valuable insights into the role of genetic diversity in determining diabetes risk within the Iranian population.

17

My second article has just been published in AJNMC. This study explores the psychometric properties of the Diabetic Patients Self Care Scale in the Iranian population (DSCS-I) through an exploratory factor analysis. The findings reveal that the DSCS-I demonstrates very good validity and reliability, highlighting its importance in assessing the self-care status of diabetic patients. Check out the full article to learn more about this valuable tool! #DiabetesResearch #SelfCare #AJNMC #PublicationAlert 📚🔬 https://lnkd.in/d5nAgmE4

16

4 Comments

📋🔍 First Iranian guideline for the diagnosis, management, and treatment of hyperlipidemia in adults 🔍📋 📚 Just Released in the Journal of Research in Medical Sciences (March 2024) 📚 Overview: This guideline offers comprehensive recommendations based on the latest scientific evidence. Key Recommendations: Diagnostic Thresholds: Initiate drug treatment in adults with low-density lipoprotein cholesterol (LDL-C) levels >190 mg/dL and triglyceride (TG) levels >500 mg/dL. Perform fasting lipid profile tests at the beginning and during treatment. Assess cardiovascular disease (CVD) risk using validated Iranian models. Lifestyle Modifications: Emphasize lifestyle changes as the primary therapeutic intervention. Pharmacotherapy: Start statins as the first-line drug treatment to reduce LDL-C levels. Consider combined treatment with other agents if LDL-C remains high despite maximum therapy. For hypertriglyceridemia, consider pharmacotherapy with statins or fibrates. Treatment Targets: Target LDL-C levels <130 mg/dL and TG levels <200 mg/dL for adults without comorbidities or risk factors. Subgroup Considerations: Tailor recommendations for specific populations, including those with CVD, stroke, diabetes, chronic kidney disease, elderly individuals, and women. 🔗 Read the full guideline: https://lnkd.in/d27PhFCQ These guidelines provide a structured approach to managing hyperlipidemia in adults, aiming to improve patient outcomes and reduce the risk of cardiovascular events. #Hyperlipidemia #Guidelines #MedicalResearch #JRMS 🩺🔬

10